Optimized Performance, Increased Coverage.
The new, enhanced LSA Assays deliver increased coverage, optimized performance, and improve the overall workflow of the LIFECODES® HLA Antibody Analysis portfolio.
LIFECODES® Single Antigen Assays (LSA) Benefits
Clear
Results
Results
High
Efficiency
Efficiency
Optimized
Performance
Performance
The Details
We strive to develop assays to increase your ability to find acceptable donors and provide new beginnings for more transplant patients. The Enhanced LSA Assays deliver increased coverage, optimized performance, and improve the overall workflow of the LIFECODES® HLA Antibody Analysis portfolio.
Improved Performance
- More comprehensively determine the sample’s antibody profile with expanded antigen panels.
- Result in fewer false positive reactions by reducing non-specific reactivity
Increased Accuracy
- Greater lot to lot reproducibility with all antigen values normalized to an external standard.
- Reduce inter and intra site variability with a new calculation for positive/negative assignments
LIFECODES Single Antigen Assay is for Research Use Only (RUO). Not for use in diagnostic procedures.
LIFECODES® Single Antigen Assays (LSA) Downloads
Resource Library
PACKAGE INSERTS (PI/ IFU), SAFETY DATA SHEETS (SDS), CERTIFICATES of ANALYSIS, LOT SPECIFIC FILES, and more can be accessed on our customer center.
Our Certifications
Experience Our Virtual Lab
Contact your sales representative for a personal tour.
Related Products
Upcoming Events,
Webinars & Workshops
Keep Up With Us
News & Blogs
Werfen Introduces NanoTYPE™ HLA-11 Plus CE— First CE-IVD HLA Typing Kit with Full-Gene Coverage for All 11 Classical HLA Genes
Werfen, a global leader in specialized diagnostics, announced the availability of NanoTYPETM HLA-11 Plus as CE-IVD (according to IVD-R), a next-generation HLA typing assay offering true full-gene coverage — from 5′UTR to 3′UTR — across all 11 classical HLA genes....
News & Blogs
Werfen acquires Omixon
Werfen has completed the acquisition of Omixon, a privately held company based in Budapest, Hungary,...
News & Blogs
PRESS RELEASE: Immucor and Pirche Announce Multi-Year Partnership
NORCROSS, Ga. and BERLIN, DE Oct. 04, 2022 (GLOBE NEWSWIRE) -- Immucor, Inc., a global...
News & Blogs
PRESS RELEASE: Immucor Announces New Innovations in Transplant Diagnostics
NORCROSS, Ga., March 04, 2022 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion...
News & Blogs
MIA FORATM NGS EXPRESS HLA Typing Software: You Spoke, We Listened!
Introducing MIA FORA NGS EXPRESS HLA Typing Software, Immucor’s next step in providing value-added user...